Mad for Madangamines

  • Author: Emma Scales
  • Published Date: 20 August 2010
  • Source / Publisher: Chemistry - A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Mad for Madangamines

Related Societies

Madangamines are a small group of complex pentacyclic alkaloids isolated from marine sponges of the order Haplosclerida, biogenetically derived from partially reduced bis-3-alkylpyridine macrocycles. Madangamine A, isolated from Xestospongia ingens by Andersen and co-workers in 1994 [1] was the first example of this new class of pentacyclic alkaloids and showed significant in vitro cytotoxicity against a number of cancer cell lines. Soon afterwards, four new members of this group, madangamines B–E, were isolated from the same sponge [2] and more recently madangamine F, also showing cytotoxic activity, has been isolated from the marine sponge Pachychalina alcaloidifera [3].


For the first time, the diazatricyclic core common to all madangamines has been enantioselectively assembled by M. Amat, J. Bosch and colleagues from the University of Barcelona, Spain. This represents a significant breakthrough in the total synthesis of these natural products. The key steps involve a stereoselective conjugate addition, ring-closing metathesis, stereoselective generation of the C–9 stereocenter, and closure of the piperidine A ring by aminohydroxylation.


References

[1] F. Kong, R. J. Andersen, T. M. Allen, J. Am. Chem. Soc. 1994, 116, 6007—6008. DOI: 10.1021/ja00092a077
[2] F. Kong, E. I. Graziani, R. J. Andersen, J. Nat. Prod. 1998, 61, 267—271. DOI: 10.1021/np970458n
[3] J. H. H. L. De Oliveira, A. M. Nascimento, M. H. Kossuga, B. C. Cavalcanti, C. O. Pessoa, M. O. Moraes, M. L. Macedo, A. G. Ferreira, E. Hajdu, U. S. Pinheiro, R. G. S. Berlinck, J. Nat. Prod. 2007, 70, 538—543. DOI: 10.1021/np060450q

Article Views: 690

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

Footer